Medications

Mylan launching cheaper, generic version of EpiPen

The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues—and looming competition threatens its near-monopoly.

Neuroscience

The resilience of brain-training hype

It was definitely déjà vu in the media today. Reuters, The New Yorker, Los Angeles Times, and more were back on the "brain training prevents dementia" bandwagon.

Health

'Credential creep' bad for health care practitioners, consumers

The outcome of a case argued before the U.S. Supreme Court last fall could potentially slow the trend of the ever-increasing number of occupations subject to state licensing, says a University of Illinois expert in the regulation ...

Health

US sues Gerber over claims on infant formula

U.S. government regulators announced Thursday they were suing Gerber, the well-known baby food maker, for claiming that its Good Start Gentle formula can prevent or reduce allergies in children.

Overweight & Obesity

TV ads nutritionally unhealthy for kids, study finds

The nutritional value of food and drinks advertised on children's television programs is worse than food shown in ads during general air time, according to University of Illinois at Chicago researchers.

page 5 from 9